Since a synergistic effect of renalase and CKD on serum ET-1 in our study, it is reasonable to speculate that increased renalase in CKD may increase circulating ET-1, which aggravates CV risk in patients with CAD. The gene discussed is RNLS; the disease is chronic kidney disease.